Q2 2024 Holdings
Filed 2024-08-14 | 13 holdings | $885.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $190.0M | 2,360,077 | 21.5% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $146.0M | 1,924,626 | 16.5% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $94.5M | 4,018,101 | 10.7% |
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $80.6M | 2,048,647 | 9.1% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $74.8M | 3,202,798 | 8.5% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $71.5M | 2,762,837 | 8.1% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $59.8M | 3,204,841 | 6.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $52.5M | 6,225,641 | 5.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $32.3M | 3,554,129 | 3.7% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $32.3M | 931,890 | 3.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $24.0M | 1,845,813 | 2.7% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $21.6M | 1,069,199 | 2.4% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $5.1M | 748,996 | 0.6% |